Literature DB >> 10656675

The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes.

C Trujillo1, R Ramírez, I D Vélez, C Berberich.   

Abstract

The kinetoplastid membrane protein-11 (KMP-11) is a major target of the humoral immune response during Leishmania-infections. The majority of sera from visceral leishmaniasis, mucocutaneous leishmaniasis and even some cutaneous leishmaniasis patients contain detectable IgG antibodies against KMP-11. We also provide evidence that this protein may act as a potent antigen in T. cruzi infections, since most Chagas sera show immunological cross-reactivity. Therefore, KMP-11 cannot be used as a specific diagnostical tool for the serodiagnosis of leishmaniasis in those regions where both, Leishmania and T. cruzi infections overlap geographically. When analyzing the subclass specificity of the antibody response to KMP-11 we observed the following order of reactivity: IgG1 > > IgG3 > IgG2 > IgG4, which is similiar to that seen in crude parasite extract. The mapping of antigenic determinants by using synthetic 20-mer peptides revealed the existence of predominantly conformational epitopes in leishmaniasis, while 50% of sera from Chagas patients reacted with a particular KMP-11 peptide. These results therefore suggest the presence of disease-specific B-cell epitopes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10656675     DOI: 10.1016/s0165-2478(99)00146-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  11 in total

1.  Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera.

Authors:  M C Thomas; M V Longobardo; E Carmelo; C Marañón; L Planelles; M E Patarroyo; C Alonso; M C López
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.

Authors:  Raymond L Houghton; Yvonne Y Stevens; Kathryn Hjerrild; Jeff Guderian; Masahiko Okamoto; Mazbahul Kabir; Steven G Reed; David A Leiby; W John W Morrow; Myriam Lorca; Syamal Raychaudhuri
Journal:  Clin Vaccine Immunol       Date:  2009-02-11

3.  Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses.

Authors:  Diego A Vargas-Inchaustegui; Lijun Xin; Lynn Soong
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

4.  Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice.

Authors:  Mohammad Reza Mohammadi; Majid Zeinali; Sussan K Ardestani; Amina Kariminia
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

5.  Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c mice.

Authors:  Juliane Schroeder; Najmeeyah Brown; Paul Kaye; Toni Aebischer
Journal:  PLoS Negl Trop Dis       Date:  2011-12-27

6.  Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach.

Authors:  Vinicio T S Coelho; Jamil S Oliveira; Diogo G Valadares; Miguel A Chávez-Fumagalli; Mariana C Duarte; Paula S Lage; Manuel Soto; Marcelo M Santoro; Carlos A P Tavares; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

7.  IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.

Authors:  Tapan Bhattacharyya; Armon Ayandeh; Andrew K Falconar; Shyam Sundar; Sayda El-Safi; Marissa A Gripenberg; Duncan E Bowes; Caroline Thunissen; Om Prakash Singh; Rajiv Kumar; Osman Ahmed; Osama Eisa; Alfarazdeg Saad; Sara Silva Pereira; Marleen Boelaert; Pascal Mertens; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

8.  Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum.

Authors:  Vahid Nasiri; Abdolhossein Dalimi; Fatemeh Ghaffarifar; Azam Bolhassani
Journal:  Iran J Parasitol       Date:  2016 Apr-Jun       Impact factor: 1.012

9.  Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.

Authors:  Ivonne D Flechas; Adriana Cuellar; Zulma M Cucunubá; Fernando Rosas; Víctor Velasco; Mario Steindel; María del Carmen Thomas; Manuel Carlos López; John Mario González; Concepción Judith Puerta
Journal:  BMC Infect Dis       Date:  2009-11-25       Impact factor: 3.090

10.  Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.

Authors:  Ana Paula Souza; Manuel Soto; Jackson M L Costa; Viviane S Boaventura; Camila I de Oliveira; Juqueline R Cristal; Manoel Barral-Netto; Aldina Barral
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.